We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+11.3%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$52.3B
AUM Growth
+$4.34B
Cap. Flow
-$146M
Cap. Flow %
-0.28%
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79

Top Buys

Rank Stock Value
1
IS
ironSource Ltd.
IS
+$136M
2
TSLA icon
Tesla
TSLA
+$119M
3
VZ icon
Verizon
VZ
+$109M
4
HD icon
Home Depot
HD
+$101M
5
PFE icon
Pfizer
PFE
+$88M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$247M
2
INTC icon
Intel
INTC
+$216M
3
F icon
Ford
F
+$145M
4
GM icon
General Motors
GM
+$143M
5
MU icon
Micron Technology
MU
+$125M

Sector Composition

Rank Sector Weight
1 Technology 25.15%
2 Healthcare 14.97%
3 Financials 14.22%
4 Consumer Discretionary 11.15%
5 Communication Services 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CURI icon
2151
CuriosityStream
CURI
$145M
$42K ﹤0.01%
+7,080
New +$59.7K
TG icon
2152
Tredegar Corp
TG
$260M
$42K ﹤0.01%
3,539
-16,110
-82% -$194K
TBRG
2153
DELISTED
TruBridge
TBRG
$41K ﹤0.01%
1,400
HRTG icon
2154
Heritage Insurance Holdings
HRTG
$864M
$39K ﹤0.01%
+6,710
New +$44.2K
CSTL icon
2155
Castle Biosciences
CSTL
$741M
$38K ﹤0.01%
+890
New +$46.5K
HYLN icon
2156
Hyliion Holdings
HYLN
$681M
$37K ﹤0.01%
+6,030
New +$43.1K
RPAY icon
2157
Repay Holdings
RPAY
$335M
$36K ﹤0.01%
+1,980
New +$38.9K
TPIC
2158
DELISTED
TPI Composites
TPIC
$35K ﹤0.01%
+2,350
New +$57.7K
HUYA
2159
Huya Inc
HUYA
$558M
$34K ﹤0.01%
4,900
PCVX icon
2160
Vaxcyte
PCVX
$8.01B
$34K ﹤0.01%
+1,420
New +$33K
SGMO
2161
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$34K ﹤0.01%
+4,590
New +$39.9K
CGEM icon
2162
Cullinan Oncology
CGEM
$1.07B
$32K ﹤0.01%
2,070
-10,142
-83% -$202K
VLDR
2163
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$32K ﹤0.01%
+6,790
New +$39.7K
IMVT icon
2164
Immunovant
IMVT
$8.23B
$31K ﹤0.01%
+3,680
New +$30.4K
ACCD
2165
DELISTED
Accolade Inc
ACCD
$31K ﹤0.01%
+1,170
New +$38.3K
BOC icon
2166
Boston Omaha
BOC
$434M
$30K ﹤0.01%
+1,060
New +$34.6K
NP
2167
DELISTED
Neenah, Inc. Common Stock
NP
$30K ﹤0.01%
650
-16,100
-96% -$790K
BNR
2168
Burning Rock Biotech
BNR
$99.1M
$29K ﹤0.01%
305
TIGR
2169
UP Fintech Holding
TIGR
$877M
$29K ﹤0.01%
5,900
IBRX icon
2170
ImmunityBio
IBRX
$7.32B
$28K ﹤0.01%
+4,560
New +$34.3K
RDUS
2171
DELISTED
Radius Health, Inc.
RDUS
$28K ﹤0.01%
+3,980
New +$58.4K
DENN
2172
DELISTED
Denny's
DENN
$26K ﹤0.01%
+1,620
New +$24.8K
GNK icon
2173
Genco Shipping & Trading
GNK
$1.09B
$25K ﹤0.01%
+1,580
New +$25.7K
ATEC icon
2174
Alphatec Holdings
ATEC
$1.33B
$24K ﹤0.01%
+2,140
New +$25.3K
OCFT
2175
DELISTED
OneConnect Financial Technology
OCFT
$23K ﹤0.01%
915

Similar funds

Ensign Peak Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Ensign Peak Advisors held 2,277 positions worth $52.3B, up 9% from $48B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ensign Peak Advisors's Q4 2021 filing shows 427 new, 521 increased, 1,052 reduced and 79 closed positions. Its largest new stake was ironSource Ltd.: 13,801,563 shares worth $107M. The largest sale was AT&T, an estimated $247M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q4 2021 buy was ironSource Ltd.: 13,801,563 shares worth $107M.
  • Ensign Peak Advisors added most to Tesla in Q4 2021, an estimated $119M increase.
  • Ensign Peak Advisors's biggest Q4 2021 reduction was AT&T, cutting an estimated $247M.
  • Ensign Peak Advisors fully exited Acceleron Pharma in Q4 2021, selling an estimated $21.5M.
  • Ensign Peak Advisors's ten largest holdings make up 26% of its $52.3B portfolio in Q4 2021.
  • Ensign Peak Advisors opened 427 new positions and closed 79 in Q4 2021.
  • Ensign Peak Advisors's portfolio value rose 9% quarter-over-quarter to $52.3B.

Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.